|
1
|
Sheng N, Yan L, Wu K, You W, Gong J, Hu L,
Tan G, Chen H and Wang Z: TRIP13 promotes tumor growth and is
associated with poor prognosis in colorectal cancer. Cell Death
Dis. 9:4022018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vu T and Datta PK: Regulation of EMT in
colorectal cancer: A culprit in metastasis. Cancers. 9:E1712017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lan Q, Lai W, Zeng Y, Liu L, Li S, Jin S,
Zhang Y, Luo X, Xu H, Lin X, et al: CCL26 participates in the
PRL-3-induced promotion of colorectal cancer invasion by
stimulating tumor-associated macrophage infiltration. Mol Cancer
Ther. 17:276–289. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu H, Zhang Y, Peña MM, Pirisi L and Creek
KE: Six1 promotes colorectal cancer growth and metastasis by
stimulating angiogenesis and recruiting tumor-associated
macrophages. Carcinogenesis. 38:281–292. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ming J, Liu N, Gu Y, Qiu X and Wang EH:
PRL-3 facilitates angiogenesis and metastasis by increasing ERK
phosphorylation and up-regulating the levels and activities of
Rho-A/C in lung cancer. Pathology. 41:118–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang F, Liang J, Wang WQ, Sun JP, Udho E
and Zhang ZY: PRL3 promotes cell invasion and proliferation by
down-regulation of Csk leading to Src activation. J Biol Chem.
282:5413–5419. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo K, Li J, Wang H, Osato M, Tang JP,
Quah SY, Gan BQ and Zeng Q: PRL-3 initiates tumor angiogenesis by
recruiting endothelial cells in vitro and in vivo. Cancer Res.
66:9625–9635. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zimmerman MW, McQueeney KE, Isenberg JS,
Pitt BR, Wasserloos KA, Homanics GE and Lazo JS: Protein-tyrosine
phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth
factor signaling and enables endothelial cell motility. J Biol
Chem. 289:5904–5913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mager LF, Wasmer MH, Rau TT and Krebs P:
Cytokine-induced modulation of colorectal cancer. Front Oncol.
6:962016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin X, Yi Z, Diao J, Shao M, Zhao L, Cai
H, Fan Q, Yao X and Sun X: ShaoYao decoction ameliorates
colitis-associated colorectal cancer by downregulating
proinflammatory cytokines and promoting epithelial-mesenchymal
transition. J Transl Med. 12:1052014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rokavec M, Öner MG, Li H, Jackstadt R,
Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et
al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated
colorectal cancer invasion and metastasis. J Clin Invest.
125:13622015. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang L, Tang C, Cao H, Li K, Pang X, Zhong
L, Dang W, Tang H, Huang Y, Wei L, et al: Activation of IL-8 via
PI3K/Akt-dependent pathway is involved in leptin-mediated
epithelial-mesenchymal transition in human breast cancer cells.
Cancer Biol Ther. 16:1220–1230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu H, Lai W, Zhang Y, Liu L, Luo X, Zeng
Y, Wu H, Lan Q and Chu Z: Tumor-associated macrophage-derived IL-6
and IL-8 enhance invasive activity of LoVo cells induced by PRL-3
in a KCNN4 channel-dependent manner. BMC Cancer. 14:3302014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jedinak A, Dudhgaonkar S and Sliva D:
Activated macrophages induce metastatic behavior of colon cancer
cells. Immunobiology. 215:242–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Erreni M, Mantovani A and Allavena P:
Tumor-associated macrophages (TAM) and inflammation in colorectal
cancer. Cancer Microenviron. 4:141–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li S, Xu F, Zhang J, Wang L, Zheng Y, Wu
X, Wang J, Huang Q and Lai M: Tumor-associated macrophages
remodeling EMT and predicting survival in colorectal carcinoma.
Oncoimmunology. 7:e13807652017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng L, Jin G, Wang L, Guo J, Meng L and
Shou C: Identification of integrin alpha1 as an interacting protein
of protein tyrosine phosphatase PRL-3. Biochem Biophys Res Commun.
342:179–183. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi G, Zheng X, Zhang S, Wu X, Yu F, Wang
Y and Xing F: Kanglaite inhibits EMT caused by TNF-α via NF-κΒ
inhibition in colorectal cancer cells. Oncotarget. 9:6771–6779.
2017.PubMed/NCBI
|
|
20
|
Zhao WB, Li Y, Liu X, Zhang LY and Wang X:
Evaluation of PRL-3 expression, and its correlation with
angiogenesis and invasion in hepatocellular carcinoma. Int J Mol
Med. 22:187–192. 2008.PubMed/NCBI
|
|
21
|
Sahai E and Marshall CJ: RHO-GTPases and
cancer. Nat Rev Cancer. 2:133–142. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang H, Quah SY, Dong JM, Manser E, Tang
JP and Zeng Q: PRL-3 down-regulates PTEN expression and signals
through PI3K to promote epithelial-mesenchymal transition. Cancer
Res. 67:2922–2926. 2007. View Article : Google Scholar : PubMed/NCBI
|
